Katherine Arnold, MD

Nerbun, Elizabeth A MD is a reputable medical facility situated in the bustling city of Washington, DC. Specializing in providing top-notch patient care, this establishment is known for its dedication to offering a wide range of healthcare services, from routine check-ups to specialized medical interventions. With a team of skilled medical professionals at the helm, Nerbun, Elizabeth A MD prides itself on delivering exceptional care across various medical fields, including but not limited to cardiology, neurology, oncology, and pediatrics. What sets Nerbun, Elizabeth A MD apart is its strong emphasis on continuous education and training, ensuring that the next generation of healthcare providers is well-equipped to deliver excellence in patient care. By fostering a culture of collaboration and innovation, this esteemed medical institution remains at the forefront of medical advancements, consistently striving to improve patient outcomes and uphold its stellar reputation in the realm of healthcare and medical excellence. Generated using this brand's available information

Mihail “Misha” Zilbermint, M.D., M.B.A., F.A.C.E. is an Associate Professor of Clinical Medicine at the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine. He is the Director of Endocrine Hospitalists at the Johns Hopkins Community Physicians, Chief and Director of Division of Endocrinology, Diabetes and Metabolism at Suburban Hospital in Bethesda, MD. Dr. Zilbermint is known for pioneering the Endocrine Hospitalist program at Johns Hopkins Medicine following the completion of his endocrinology fellowship at the National Institutes of Health. This consultation service is dedicated to enhancing glycemic control among hospitalized patients, effectively reducing patient stays and saving the hospital hundreds of thousands of dollars. His commitment to innovation earned his specialized diabetes team the Johns Hopkins Innovations in Clinical Care Award. Over the years, Dr. Zilbermint has been sought after for his expertise in endocrinology and diabetes, with a focus on inpatient diabetes management, diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and diabetes technology. His reputation extends nationally and internationally, as he is often invited to speak at conferences and is sought after for consultations worldwide. His extensive research interests encompass diabetes initiatives, hypoglycemia reduction, continuous glucose monitoring (CGM) systems, COVID-19 vaccines and hyperglycemia, COVID-19 and diabetes, genetic causes of hypertension, primary aldosteronism, rare adrenal tumors, and the interplay between diabetes and climate change. Dr. Zilbermint leads the JHCP Academy Clinical Excellence, which helps to recognize and promote clinical excellence about community-based clinicians. Beyond his clinical and research contributions, Dr. Zilbermint is a dedicated educator. He imparts his expertise to endocrinology fellows, hospitalists, pharmacy residents, and advanced practice providers, furthering the advancement of the medical community.